Search Orphan Drug Designations and Approvals
-
Generic Name: | 5'-CTATCTGUC*G1TTCTCTGU-3'.17 Na+ |
---|---|
Date Designated: | 03/31/2015 |
Orphan Designation: | Treatment of diffuse large B-cell lymphoma. |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Idera Pharmaceuticals, Inc. 505 Eagleview Boulevard Suite 212 Exton, Pennsylvania 19341 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-